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Nearly all mitochondrial proteins are coded by nuclear genome and must be
transported across mitochondrial membranes to their final functional loca-
tions. This translocation of partially folded proteins is accomplished by
several multi-protein complexes in the mitochondrial outer and inner mem-
branes. Tom40 is the central pore-forming subunit of the multi-protein trans-
locase complex in the mitochondrial outer membrane (TOM). Although much
is known regarding the general organization of the TOM complex, the molec-
ular basis of Tom40’s ability to translocate both acidic pre-sequences of
matrix proteins and hydrophobic membrane proteins remains unclear. Here
we have functionally investigated the role of structural domains of Tom40.
Fungal Tom40 is predicted to be comprised of a membrane-spanning beta-
barrel domain with strongly conserved alpha-helical domains at N- and
C-termini. We have refolded and purified a full-length (FL) fungal Tom40
and N-terminal truncation mutant (Tom40-319), and characterized their elec-
trophysiological behavior in planar lipid membranes. Our results demonstrate
that recombinant Tom40 forms cation-selective channels with four well-
defined conductive states, thus reconciling conflicting reports in literature
regarding conductance of the channel. High cation selectivity of all con-
ducting sublevels of Tom40 suggests the presence of a constriction zone
within the channel lumen. Tom40-319 has a lower selectivity for cations, sug-
gesting that the N-terminal alpha-helix is located in the channel lumen. Both
Tom40-FL and the 319 mutant interact with specific polycationic precursor
peptide of the F1b subunit of ATP synthase in a concentration- and
voltage-dependent manner. However, Tom40-319 has a lower apparent affin-
ity for pF1b than FL, which also suggests that the N-terminal alpha-helix is
located inside the channel lumen. Furthermore, both Tom40 FL and the 319
mutant do not show interactions with SynB2, a synthetic peptide of similar
length and charge as pF1b, thus confirming Tom40 specificity for the prese-
quence peptide.
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Mitochondrial dysfunction has been implied in Parkinson’s disease (PD) lead-
ing to neuronal death. Alpha-synuclein aggregations have been shown to be a
pathological hallmark in PD patients. This current study investigates a possible
effect of alpha-synuclein on mitochondrial health.
We have used fluorescence imaging and TMRM to measure the mitochondrial
membrane potential (Dcm) in mouse primary co-cultures of neurons and astro-
cytes and human iPS derived neurons.
Human iPS derived neurons bearing a triplication of the alpha-synuclein gene
displayed a significantly lower Dcm (61.453.9% of control). Importantly,
basal Dcm in alpha-synuclein overexpressing cells was dependent on the age
of cells which possibly reflects an increase in expression levels of alpha-
synuclein.
Application of oligomycin to alpha-synuclein overexpressing neurons induced
a mitochondrial depolarisation, suggesting that Dcm is partially maintained
through the hydrolysis of ATP by F1F0-ATPases due to an impaired mitochon-
drial respiration.
The current study found also that the stimulation of TMRM-loaded human neu-
rons with a high laser power (565 nm) produced ROS and induced a rapid drop
in Dcm which can be partially rescued by a pre-incubation with an inhibitor of
the permeability transition pore (PTP) cyclosporine A. The ROS-induced PTP
opening appeared much faster in human alpha-synuclein overexpressing neu-
rons when compared to control neurons. Additionally, application of the
same method to primary neuronal mouse cultures demonstrated that pre-
incubation of these cells with monomeric or oligomeric alpha-synuclein
induced significantly faster PTP opening.
This work was supported by the MRC and Wellcome Trust.2983-Pos Board B675
Functional, Structural, and Computational Approaches to the Molecular
Mechanism of Vdac Gating
Oscar Teijido Hermida1, Sergei Yu Noskov2, Rachna Ujwal3,
Jeff Abramson3, Matthew T. Eddy4, Robert G. Griffin4, SergeyM. Bezrukov1,
Tatiana K. Rostovtseva1.
1Program on Physical Biology, National Institutes of Heath (NIH), Bethesda,
MD, USA, 2Department of Biological Sciences, Institute for Biocomplexity
and Bioinformatics, University of Calgary, Calgary, AB, Canada,
3Department of Physiology, David Geffen School of Medicine, UCLA, Los
Angeles, CA, USA, 4Department of Chemistry, Francis Bitter Magnet
Laboratory, MIT, Cambridge, MA, USA.
The Voltage-Dependent Anion Channel (VDAC) controls the fluxes of ATP/
ADP and other respiratory substrates across the mitochondrial outer membrane
(MOM) by using its characteristic ability to switch or ‘‘gate’’ between high-
conducting ‘‘open’’ and low-conducting ‘‘closed’’ states. Only the open state
of VDAC is permeable for most of the negatively-charged mitochondrial me-
tabolites. Therefore, unveiling the molecular mechanism by which VDAC con-
trols transport of metabolites across the MOM would provide insightful
information about the regulation of mitochondrial respiration and metabolism.
The conformational transitions underlying VDAC voltage-gating are still under
debate although all models agree on a crucial role of the N-terminus in this pro-
cess, either by being a part of a mobile voltage sensor domain, which slides in
and out of the channel lumen, or by moving independently upon gating. It was
shown that crosslinking the N-terminus a-helix to the b-barrel wall of recom-
binant VDAC1 reconstituted into planar lipid membranes did not prevent the
gating of the channel. Furthermore, the point mutation S193E resulting in the
addition of an extra negative charge inside the pore did not affect significantly
the classic gating behavior observed in the WT VDAC1. This is consistent with
MAS NMR results showing similar secondary structures between WT and
S193E VDAC1 for the presumably open state. Computational analysis of
VDAC1 WT and S193E confirms the functional data and suggests that the sur-
face charge of the b-barrel wall of VDAC1 is an important determinant of the
N-terminus packing and stability. These data lead us to propose a new mecha-
nism of VDAC gating where N-terminus remains inside the pore during gating
screening the S193 residue and the b-barrel is flexible and undergoes conforma-
tional changes that cause a partial constriction that affects selectivity upon tran-
sition to the closed states.
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Dysfunction of mitochondrial enzyme complexes, production of reactive
oxygen species, mitochondrial outer membrane (MOM) permeabilization,
enhanced apoptosis, and structural alterations of mitochondria are believed
to be crucial for the onset and progression of Parkinson’s disease (PD). Direct
participation of small, intrinsically disordered neuronal protein a-synuclein
(a-syn) in the pathogenesis of PD has been well documented. However,
the mechanisms of a-syn toxicity remain elusive. Here, we studied interac-
tion of a-syn with the major channel of MOM, voltage-dependent anion
channel (VDAC), reconstituted into planar lipid membranes. We found that
at nanomolar concentrations a-syn reversibly blocks VDAC in a voltage-
dependent manner. Negative potentials applied from the side of a-syn
addition promote the reaction, thus implicating its acidic C-terminus in the
channel blockage. a-syn induces two well-defined blocked states: the first
state is ~ 60% and the second, deeper blocked state is ~ 17% of the open state
conductance. The probability of the second blocked state dramatically in-
creases with the voltage. We found that selectivity of the a-syn-blocked
states is less anionic than that of the open state. Kinetic analysis of a-syn-
induced blockage events showed that the on-rate strongly increases with
the applied voltage. The blocked time distributions are described by single
exponents for both blocked states, with their average values displaying
biphasic voltage dependence thus suggesting that a-syn is able to translocate
through VDAC. This could explain the previously reported interaction of
a-syn with mitochondrial complex-I. Even more importantly, because
VDAC is a major conduit for the fluxes of ATP, ADP, and other respiratory
substrates across MOM, we hypothesize that this newly demonstrated regula-
tion of VDAC by a-syn blockage could constitute a new mechanism of
mitochondrial involvement in PD pathology and perhaps also in general
neurodegenerative pathogenesis.
